March 7
- Recommend to purchase Inotek Pharmaceuticals Corporation (ITEK) at $6.45 to 6.73. Currently at an 8 month low, July the stock hit 19.45. CEO is presenting at Monday's Annual Health Care Conference at 2pm eastern. May see a significant increase in the stock price in the afternoon. I am very positive on this stock until Octobers phase 3 release of trabodensoson.
Purchased ITEK at $6.50, low for the day.
ReplyDelete